CureCervicalCancer (EIN 463942138) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2013

Legal Domicile

Principal Officer

BENJAMIN Gordon

Phone

3106013002

Tax Period

2024-01-01 to 2024-12-31

CureCervicalCancer, founded in 2013, is a small nonprofit in the International Affairs sector that reported $842K in total revenue in fiscal year 2024. Revenue decreased 6% compared to the prior year. Expenses of $975K exceeded revenue, resulting in a 16% operating deficit.

Mission

DEDICATED TO THE EARLY DETECTION AND PREVENTION OF CERVICAL CANCER AROUND THE GLOBE FOR THE WOMEN WHO NEED IT MOST.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $841,940

Program Service Revenue $0

Investment Income $114

Other Revenue $0

TOTAL REVENUE $842,054

Expense Breakdown

Grants Paid $0

Salaries & Benefits $316,999

Fundraising Expenses $33,300

Program Expenses $886,020

Other Expenses $657,784

TOTAL EXPENSES $974,783

Year-over-Year Comparison

	2024	2023	Change
Revenue	$842,054	$892,819	-0.1%
Expenses	$974,783	$796,203	+0.2%
Net Income	$-132,729	$96,616	-2.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
REBECCA LEPSIK	executive director	40.0	Highest	$172,580	$0	$172,580
PATRICIA GORDON	PRESIDENT/BOARD CHAIR	10.0	Officer Director	$0	$0	$0
JUDY CARMEL	board member	2.0	Director	$0	$0	$0
JUDY LANER	board member	2.0	Director	$0	$0	$0
BENJAMIN GORDON	board member	2.0	Director	$0	$0	$0
Anne Vandenabeele	BOARD MEMBER	2.0	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$842,054	$974,783	$393,850	$-132,729
2023	$892,819	$796,203	$528,065	$96,616
2022	$681,125	$906,114	$428,008	$-224,989
2021	$778,019	$830,050	$645,973	$-52,031
2020	$702,401	$444,153	$696,102	$258,248
2019	$488,103	$536,711	$444,095	$-48,608
2018	$425,760	$453,748	$486,975	$-27,988

CureCervicalCancer